In line with the overall growth of clinical trials in Latin America and particularly in Argentina, our site experienced a 77.8% year-over-year increase in ongoing clinical studies.
Q2 2025 reflects the number of active studies at our site. As further evidence of regional growth, there is a clear predominance of enrolling protocols (62%) over closed ones.
